AU2003255621A1 - Topical use of at least one double-stranded rna oligonucleotide (ds rna) - Google Patents

Topical use of at least one double-stranded rna oligonucleotide (ds rna)

Info

Publication number
AU2003255621A1
AU2003255621A1 AU2003255621A AU2003255621A AU2003255621A1 AU 2003255621 A1 AU2003255621 A1 AU 2003255621A1 AU 2003255621 A AU2003255621 A AU 2003255621A AU 2003255621 A AU2003255621 A AU 2003255621A AU 2003255621 A1 AU2003255621 A1 AU 2003255621A1
Authority
AU
Australia
Prior art keywords
double
rna
stranded rna
topical use
rna oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003255621A
Other versions
AU2003255621A8 (en
Inventor
Christine Collin-Djangone
Albert Duranton
Francis Pruche
Jean-Thierry Simonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0206796A external-priority patent/FR2840217B1/en
Application filed by LOreal SA filed Critical LOreal SA
Publication of AU2003255621A1 publication Critical patent/AU2003255621A1/en
Publication of AU2003255621A8 publication Critical patent/AU2003255621A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Birds (AREA)
  • Endocrinology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention relates to a novel use of at least one double-stranded RNA oligonucleotide (ds RNA) for a topical application and topical compositions comprising at least one double-stranded RNA oligonucleotide encapsulated within a physiologically-acceptable medium. The invention further relates to a cosmetic treatment method using at least one double-stranded RNA oligonucleotide.
AU2003255621A 2002-06-03 2003-06-02 Topical use of at least one double-stranded rna oligonucleotide (ds rna) Abandoned AU2003255621A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0206796A FR2840217B1 (en) 2002-06-03 2002-06-03 COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA OLIGONUCLEOTIDE (DSRNA) AND USES THEREOF
FR02/06796 2002-06-03
US38672002P 2002-06-10 2002-06-10
US60/386,720 2002-06-10
PCT/FR2003/001648 WO2003101376A2 (en) 2002-06-03 2003-06-02 Topical use of at least one double-stranded rna oligonucleotide (ds rna)

Publications (2)

Publication Number Publication Date
AU2003255621A1 true AU2003255621A1 (en) 2003-12-19
AU2003255621A8 AU2003255621A8 (en) 2003-12-19

Family

ID=29713354

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003255621A Abandoned AU2003255621A1 (en) 2002-06-03 2003-06-02 Topical use of at least one double-stranded rna oligonucleotide (ds rna)

Country Status (8)

Country Link
EP (1) EP1513482B1 (en)
JP (1) JP4499554B2 (en)
AT (1) ATE464038T1 (en)
AU (1) AU2003255621A1 (en)
CA (1) CA2485111A1 (en)
DE (1) DE60332112D1 (en)
ES (1) ES2342826T3 (en)
WO (1) WO2003101376A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254214A1 (en) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonucleotides for the treatment of degenerative skin symptoms by RNA interference
GB0307914D0 (en) * 2003-04-07 2003-05-14 Univ Dundee Cytochrome p450
AU2004285134B2 (en) * 2003-10-21 2012-01-19 Dyad Pharmaceutical Corporation Methods and compositions for treating 5alpha-reductase type 1 and type 2 dependent conditions
DE102004025881A1 (en) 2004-05-19 2006-01-05 Beiersdorf Ag Oligoribonucleotides for influencing hair growth
WO2006040446A1 (en) * 2004-10-07 2006-04-20 L'oreal Method for shaping keratin fibres
WO2006040447A1 (en) * 2004-10-07 2006-04-20 L'oreal Method for cosmetic treatment of keratin fibres and use of a transglutaminase modulator
US9139850B2 (en) 2005-05-19 2015-09-22 L'oreal Vectorization of dsRNA by cationic particles and topical use
FR2885813B1 (en) * 2005-05-19 2008-01-11 Oreal VECTORIZATION OF DSRNA BY CATIONIC PARTICLES AND THEIR USE ON SKIN MODEL.
FR2885808B1 (en) * 2005-05-19 2007-07-06 Oreal VECTORIZATION OF DSRNA BY CATIONIC PARTICLES AND TOPICAL USE.
FR2890859B1 (en) * 2005-09-21 2012-12-21 Oreal DOUBLE-STRANDED RNA OLIGONUCLEOTIDE INHIBITING TYROSINASE EXPRESSION
JP4981381B2 (en) * 2006-08-04 2012-07-18 株式会社ナリス化粧品 Skin external preparation for whitening
JP2008115101A (en) * 2006-11-02 2008-05-22 Naris Cosmetics Co Ltd Skin-bleaching composition
TWI382849B (en) * 2007-10-29 2013-01-21 Mello Biotech Taiwan Co Ltd Method of producing cosmetic product for skin care in ways of gene silencing effect and genetic recombinant nucleic acids encoding gene silencing effector
FR2940977B1 (en) * 2009-01-13 2016-11-18 Oreal USE OF COMPLEX FORMS OF THE CALMODULIN-LIKE SKIN PROTEIN CLSP PROTEIN
FR2986233B1 (en) 2012-02-01 2014-02-28 Regentis Internat BIFUNCTIONAL PEPTIDE
FR3043695B1 (en) 2015-11-17 2019-10-25 ISP Investments LLC. PROCESS FOR OBTAINING AQUEOUS EXTRACT ENRICHED IN SMALL RNA FROM PLANT MATERIAL AND EXTRACTS FROM THE PROCESS
FR3106754B1 (en) 2020-02-04 2022-01-07 Isp Investments Llc METHOD FOR OBTAINING AN AQUEOUS LAVENDER EXTRACT, COMPOSITIONS COMPRISING SUCH AN EXTRACT AND THEIR COSMETIC USES
US20230167448A1 (en) * 2020-04-03 2023-06-01 Medrx Co., Ltd. Double Stranded RNA Specifically Inhibiting Expression of IL-23 and Pharmaceutical Composition Comprising Same
FR3116438B1 (en) 2020-11-23 2022-10-14 Isp Investments Llc METHOD FOR OBTAINING AQUEOUS EXTRACTS FROM TEA LEAVES, COMPOSITIONS COMPRISING SUCH EXTRACTS AND THEIR COSMETIC USES
FR3125425A1 (en) 2021-07-22 2023-01-27 Isp Investments Llc EXTRACT OF BLACK TEA LEAVES, COMPOSITIONS COMPRISING THEM AND COSMETIC USES THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927444D0 (en) * 1999-11-19 2000-01-19 Cancer Res Campaign Tech Inhibiting gene expression
FR2804960B1 (en) * 2000-02-11 2005-06-24 Lvmh Rech NOVEL OLIGONUCLEOTIDES AND USE OF OLIGONUCLEOTIDES MODULATING THE EXPRESSION OF TYROSINASE AND TYROSINASE-RELATED-PROTEIN 1 AS DEPIGMENTING AGENTS

Also Published As

Publication number Publication date
EP1513482B1 (en) 2010-04-14
EP1513482A2 (en) 2005-03-16
WO2003101376A3 (en) 2004-05-06
JP2005530812A (en) 2005-10-13
DE60332112D1 (en) 2010-05-27
ATE464038T1 (en) 2010-04-15
ES2342826T3 (en) 2010-07-15
JP4499554B2 (en) 2010-07-07
AU2003255621A8 (en) 2003-12-19
WO2003101376A2 (en) 2003-12-11
CA2485111A1 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
AU2003255621A1 (en) Topical use of at least one double-stranded rna oligonucleotide (ds rna)
AU2001268126A1 (en) Compositions, kits, and methods for promoting defined health benefits
AU2001276048A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
WO2004080406A3 (en) Therapeutic compositions
AU2002311903A1 (en) Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
AU2003235403A1 (en) Method of utilizing physiological activity of rare saccharide and compositions containing rare saccharide
AU7621600A (en) Human rnase h and oligonucleotide compositions thereof
AU2002258066A1 (en) Dermatological and cosmetic compositions
EP1927587A3 (en) Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
GB0500265D0 (en) Methods and compositions relating to labeled rna molecules that reduce gene expression
AU3227700A (en) Skin sanitizing compositions
AU2001275155A1 (en) Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same
AU2003265972A1 (en) Composition and method to whiten skin
AU5647601A (en) Hair treatment compositions
IL161039A0 (en) Mupirocin compositions for topical use, and improved process of making same and methods of using same
AU2001268232A1 (en) Compositions, methods, and kits relating to resistin-like molecules
AU2003277046A1 (en) Cosmetic rejuvenating and healing product, method of its manufacture and uses thereof
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
AU2001269730A1 (en) Low carbohydrate compositions, kits thereof, and methods of use
AU2002342865A1 (en) Hair treatment compositions
WO2003073988A3 (en) Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
WO2004026892A3 (en) Fragmentation of dna
AU2003290970A1 (en) Compositions and method for treating affective, painful or allergic disorders
AU2003275433A1 (en) Compositions and methods for treating pain
AU2001253528A1 (en) Methods and compositions for culturing spirochetes and treating spirochetal diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase